New World Holds Firm During Slow Weekend
|Title||Release Date||Market Share||Weekend||Total||Screens|
|2||Miracle in Cell No.7||13/01/23||16.70%||291,884||12,177,983||433|
|4||Oz: The Great and Powerful (us)||13/03/07||13.60%||208,962||228,696||425|
|5||Jack the Giant Slayer (us)||13/02/28||8.60%||147,478||885,989||364|
|6||Zero Dark Thirty (us)||13/03/07||3.50%||61,171||72,222||258|
|7||The Berlin File||13/01/30||3.40%||56,401||7,100,309||287|
|8||12 Chinese Zodiac Heads (cn)||13/02/27||2.40%||41,665||296,010||187|
Leading the fray for the the third time was the gang epic New World which took in another 508,893 spectators to lift its total well over 3.3 million admissions. It's a big result for a genre pic but its 40% decline will prevent it from getting close to last year's hit Nameless Gangster, which almost went over the five million mark.
CJ's supernatural thriller Psychometry had a bad start with 242,319 admissions. Despite the pairing of popular stars Kim Gang-woo and TV's Kim Beom, the youth demographic didn't make it out for this one. Perhaps not surprising as they are not the most reliable group to count on shelling out money for the theater these days.
Oz: The Great and Powerful began its run with 208,962, a fraction of its US bow, while Jack the Giant Slayer took in another 147,478 as it stumbled 75% in its sophomore frame.
The biggest film that will come out next week is Spielberg's Lincoln but I doubt this is going to crash the chart so perhaps New World will have a fourth weekend at the top of the chart. In any case it will likely be another depressed weekend.
The Korean Box Office Update is a weekly feature which provides detailed analysis of film box office sales over the Friday to Sunday period in Korea. It appears every Sunday night (Korean Standard Time) on Modern Korean Cinema. For other weekly features, take a look at Korean Cinema News and the Weekly Korean Reviews. Reviews and features on Korean film also appear regularly on the site.
To keep up with the best in Korean film you can sign up to our RSS Feed, like us on Facebook, or follow us on Twitter.